SCHEDULE 13G: Sio Capital Management Discloses 2.45% Passive Stake in Vaxart, Inc.
Beneficial Ownership Filing
Sio Capital Management, LLC has filed a Schedule 13G, reporting a passive beneficial ownership of 2.45% of Vaxart, Inc.'s common stock as of March 31, 2025.
Summary
- Sio Capital Management, LLC reported beneficial ownership of 5,583,448 shares of Vaxart, Inc. common stock.
- This stake represents 2.45% of Vaxart's total outstanding common stock.
- The ownership is passive, indicating the shares were acquired and are held in the ordinary course of business, without the purpose of changing or influencing control of Vaxart.
- Sio Capital Management, LLC, acting as a registered investment adviser, holds these shares for the benefit of certain affiliated funds.
- The percentage of ownership is calculated based on 228,208,284 shares of common stock outstanding as of March 26, 2025, as reported by Vaxart in its Form Pre-14A.
- Sio Capital Management, LLC possesses shared voting power and shared dispositive power over all 5,583,448 shares.
Sentiment
Score: 5
Explanation: The document is a factual, routine regulatory filing disclosing a passive ownership stake. It contains no positive or negative commentary on the issuer's performance or prospects, thus maintaining a neutral sentiment.
Future Outlook
NA
Industry Context
This filing indicates a passive investment by an investment adviser in Vaxart, Inc., a biotechnology company. Such filings are routine disclosures for significant passive stakes and do not inherently reflect broader industry trends beyond the general activity of investment funds.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant passive investor's stake, which can be viewed as a vote of confidence or simply a portfolio allocation.
- Management: Awareness of a significant passive shareholder, though without intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Date of Vaxart's reported common stock outstanding in Form Pre-14A. |
| 03/31/2025 | Date of event which requires the filing of this statement (beneficial ownership stake). |
| 04/04/2025 | Date the Schedule 13G was filed with the SEC. |
Keywords
Vaxart Inc., Sio Capital Management, Schedule 13G, beneficial ownership, common stock, passive investment, SEC filing, investment adviser, VXRT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.